JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB191881

Anti-Lin28B antibody [EPR18717]

Be the first to review this product! Submit a review

|

(15 Publications)

Rabbit Recombinant Monoclonal Lin28B antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Recombinant full length protein - Human samples. Cited in 15 publications.

View Alternative Names

CSDD2, LIN28B, Protein lin-28 homolog B, Lin-28B

12 Images
Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)

ab191881 staining Lin28B in wild-type HEK293 cells (top panel) and Lin28B knockout HEK293 cells (bottom panel). The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab191881 at 10μg/ml and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 μg/ml (shown in pseudo color red). Nuclear DNA was labelled in blue with DAPI.

Image was taken with a high-content analysis system (Perkin Elmer, Operetta CLS™).

Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized JAR (Human placenta choriocarcinoma cell line) cells labeling Lin28B with ab191881 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasm and nuclear staining on JAR cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).

The negative controls are as follows :
-ve control 1 : ab191881 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Lin28B antibody [EPR18717] (AB191881)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized K562 (Human chronic myelogenous leukemia cells from bone marrow) cells labeling Lin28B with ab191881 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasm and nuclear staining on K562 cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).

The negative controls are as follows :
-ve control 1 : ab191881 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Lab

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Lanes 1 - 4 : Merged signal (red and green). Green - ab191881 observed at 35 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.

ab191881 was shown to react with Lin28B in wild-type HEK-293 cells in Western blot with loss of signal observed in LIN28B knockout sample. Wild-type HEK-293 and LIN28B knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab191881 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution

Lane 1:

Wild-type HEK293 cell lysate at 20 µg

Lane 2:

LIN28B knockout HEK293 cell lysate at 20 µg

Lane 3:

HepG2 cell lysate at 20 µg

Lane 4:

K562 cell lysate at 20 µg

Predicted band size: 27 kDa

Observed band size: 35 kDa

false

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Supplier Data

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution

All lanes:

Human testis lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 27 kDa

Observed band size: 30 kDa

false

Exposure time: 3min

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Supplier Data

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution

Lane 1:

K562 (Human chronic myelogenous leukemia cells from bone marrow) whole cell lysate at 20 µg

Lane 2:

HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 27 kDa

Observed band size: 30 kDa

false

Exposure time: 5s

Flow Cytometry (Intracellular) - Anti-Lin28B antibody [EPR18717] (AB191881)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Lin28B antibody [EPR18717] (AB191881)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed K562 (Human chronic myelogenous leukemia cells from bone marrow) cells labeling Lin28B with ab191881 at 1/150 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.

Immunoprecipitation - Anti-Lin28B antibody [EPR18717] (AB191881)
  • IP

Supplier Data

Immunoprecipitation - Anti-Lin28B antibody [EPR18717] (AB191881)

Lin28B was immunoprecipitated from 1mg of K562 (Human chronic myelogenous leukemia cells from bone marrow) whole cell lysate with ab191881 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab191881 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : K562 whole cell lysate 10ug (Input).

Lane 2 : ab191881 IP in K562 whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab191881 in K562 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 5 seconds.

All lanes:

Immunoprecipitation - Anti-Lin28B antibody [EPR18717] (ab191881)

Predicted band size: 27 kDa

false

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Lab

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Lanes 1-4 : Merged signal (red and green). Green - ab191881 observed at 36 kDa. Red - loading control ab7291 observed at 50 kDa.

ab191881 Anti-Lin28B antibody [EPR18717] was shown to specifically react with Lin28B in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab265066 (knockout cell lysate ab257504) was used. Wild-type and Lin28B knockout samples were subjected to SDS-PAGE. ab191881 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/1000 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

LIN28B knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human LIN28B knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-lin28b-knockout-hek-293t-cell-line-ab265066'>ab265066</a>)

Lane 3:

HepG2 cell lysate at 20 µg

Lane 4:

SW480 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 27 kDa

Observed band size: 36 kDa

false

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Supplier Data

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Blocking/Dilution buffer : 5% NFDM/TBST.

Recombinant Human Lin28B protein contains aa1-250 with His-Tag®.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution

All lanes:

Recombinant full length Human Lin28B protein at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 27 kDa

false

Exposure time: 1s

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Supplier Data

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution

All lanes:

NCCIT (Human pluripotent embryonic carcinoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 27 kDa

Observed band size: 30 kDa

false

Exposure time: 15s

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)
  • WB

Supplier Data

Western blot - Anti-Lin28B antibody [EPR18717] (AB191881)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Lin28B antibody [EPR18717] (ab191881) at 1/2000 dilution

All lanes:

Human placenta lysate at 20 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 27 kDa

Observed band size: 30 kDa

false

Exposure time: 3min

  • Carrier free

    Anti-Lin28B antibody [EPR18717] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18717

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, Flow Cyt (Intra), WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1-10 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/150", "FlowCytIntra-species-notes": "<p></p>" }, "Recombinant full length protein - Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Suppressor of microRNA (miRNA) biogenesis, including that of let-7 and possibly of miR107, miR-143 and miR-200c. Binds primary let-7 transcripts (pri-let-7), including pri-let-7g and pri-let-7a-1, and sequester them in the nucleolus, away from the microprocessor complex, hence preventing their processing into mature miRNA (PubMed : 22118463). Does not act on pri-miR21 (PubMed : 22118463). The repression of let-7 expression is required for normal development and contributes to maintain the pluripotent state of embryonic stem cells by preventing let-7-mediated differentiation. When overexpressed, recruits ZCCHC11/TUT4 uridylyltransferase to pre-let-7 transcripts, leading to their terminal uridylation and degradation (PubMed : 19703396). This activity might not be relevant in vivo, as LIN28B-mediated inhibition of let-7 miRNA maturation appears to be ZCCHC11-independent (PubMed : 22118463). Interaction with target pre-miRNAs occurs via an 5'-GGAG-3' motif in the pre-miRNA terminal loop. Mediates MYC-induced let-7 repression (By similarity). When overexpressed, isoform 1 stimulates growth of the breast adenocarcinoma cell line MCF-7. Isoform 2 has no effect on cell growth.
See full target information LIN28B

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:2863 PubMed40128181

2025

Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Yan,Xue Shi,Yun Zhao,Xiaoyu Liu,Xueming Jia,Le Gao,Jiahe Yuan,Aijun Liao,Hiroshi Yasui,Xiaobin Wang,Xiaotian Wang,Rui Zhang,Huihan Wang

JCI insight 8: PubMed37991019

2023

N6-methyladenosine-mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yun Liu,Jun Zhang,Fang Cao,Xiaobao Dong,Jie Li,Yanna Cao,Zhanglin Li,Yan Guo,Jie Yan,Yuanyuan Liu,Qiang Zhao

Nature communications 14:6885 PubMed37898598

2023

The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium.

Applications

Unspecified application

Species

Unspecified reactive species

Zhaoqi Shu,Minghe Fan,Bo Tu,Zhiheng Tang,Haojie Wang,Haimeng Li,Hengchao Li,Meng Yuan,Jingru Bai,Sihan Huo,Lina Wang,Wei-Guo Zhu,Wei Wang,Xiaoyun Liu,Shaokun Shu,Ying Zhao

Experimental and therapeutic medicine 26:528 PubMed37869644

2023

Metformin regulates the LIN28B‑mediated JNK/STAT3 signaling pathway through miR‑140‑3p in subretinal fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhijuan Hua,Wenchang Yang,Dongli Li,Yixin Cui,Lu Shen,Lingna Rao,Yuxiang Zheng,Qiying Zhang,Wenyi Zeng,Yi Gong,Ling Yuan

Journal of cellular and molecular medicine 27:1384-1397 PubMed37005492

2023

Lin28 promoting the protective effect of PMSCs on hepatic ischaemia-reperfusion injury by regulating glucose metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Zhou,Junbo Li,Jin Wang,Huifang Yang,Xiaoyun Xie,Zhishui Chen,Bo Zhang

Bioengineered 13:7564-7578 PubMed35282771

2022

DOCK9 antisense RNA2 interacts with LIN28B to stabilize Wnt5a and boosts proliferation and migration of oxidized low densitylipoprotein-induced vascular smooth muscle cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jiachong Shi,Bo Zhou,Zhi Tian

PloS one 16:e0255971 PubMed34424910

2021

TCF21 regulates miR-10a-5p/LIN28B signaling to block the proliferation and invasion of melanoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Haijun Zhu,Mengshi Kang,Xinping Bai

Molecular medicine reports 23: PubMed34227673

2021

Estrogen 17β‑estradiol accelerates the proliferation of uterine junctional zone smooth muscle cells via the let‑7a/Lin28B axis in adenomyosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jun-Hua Huang,Hua Duan,Sha Wang,Yi-Yi Wang

Cancer biology & therapy 22:311-323 PubMed33879018

2021

LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Jutang Li,Wei Dong,Qixia Jiang,Fenglian Zhang,Hui Dong

Molecular therapy. Nucleic acids 23:552-564 PubMed33510943

2021

Transfer of microRNA-25 by colorectal cancer cell-derived extracellular vesicles facilitates colorectal cancer development and metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Shanchao Wang,Zeyan Zhang,Qianfu Gao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com